Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott’s Expectation Accurate: U.S. Nutritional Product Sales Down

This article was originally published in The Tan Sheet

Executive Summary

International sales for Abbott Laboratories' nutritional products increased 13.4 percent in its fiscal 2007 first quarter, but the firm's expectation of a decrease in its U.S. nutritional sales proved accurate

You may also be interested in...



Similac, Pediasure Drive Abbott’s Ross Sales In 2007

Similac, PediaSure and the launch of NutriPals bars and shakes drove sales by Abbott Laboratories' Ross U.S. Nutritionals unit up 3 percent to $624 million in its fourth quarter, according to Abbott President and COO Rick Gonzalez

Abbott Singapore Nutritionals Plant Will Be Operational In 2008, Firm Says

The construction of a $280 mil. nutritional powder manufacturing plant in Singapore by Abbott Laboratories will help the company achieve its goal of expanding its presence in the Asian nutritionals market, the firm said during a groundbreaking ceremony April 21

Shuttered US Supplement Firm Meets Recall Deadline, But Schumer Says FDA Late Cleaning Up Industry

While contract manufacturer ABH Nature' complied with consent decree, Sen. Chuck Schumer says FDA is late in enforcing against noncompliant firms across the supplement sector. Other recent consumer health recalls include more OTC ranitidine tablets due to the potential carcinogen NDMA found in the heartburn ingredient and four versions of Sure 48HR Anti-Perspirant & Deodorant with labeling errors.

Topics

UsernamePublicRestriction

Register

PS100415

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel